196 related articles for article (PubMed ID: 37195431)
21. What is the appropriate strategy for diagnosing NAFLD using ultrasonography in obese children?
Lee JH; Jeong SJ
World J Pediatr; 2017 Jun; 13(3):248-254. PubMed ID: 28101773
[TBL] [Abstract][Full Text] [Related]
22. Ultrasound Attenuation Imaging vs MRI-PDFF, Echogenicity and Liver Function for Assessing Degree of Steatosis in NAFLD and Non-NAFLD Patients.
Thomas M; Dighe M; Kolokythas O; Zecevic M; Wilson A; Erpelding T; Dubinsky TJ
Ultrasound Q; 2023 Dec; 39(4):188-193. PubMed ID: 37543732
[TBL] [Abstract][Full Text] [Related]
23. [Applied research of ultrasound attenuation parameter in the diagnosis of metabolic dysfunction-associated fatty liver disease].
Hou MM; Yuan XW; Wang YQ; Zhang Y; Zhang SY; Yu SH; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):290-296. PubMed ID: 35462485
[No Abstract] [Full Text] [Related]
24. Diagnostic performance of ultrasound hepatorenal index for the diagnosis of hepatic steatosis in children.
Frankland MP; Dillman JR; Anton CG; Coley BD; Nasser MP; O'Hara SM; Li Y; Trout AT
Pediatr Radiol; 2022 Jun; 52(7):1306-1313. PubMed ID: 35229183
[TBL] [Abstract][Full Text] [Related]
25. Relationship Between Greyscale Ultrasound Grading of Hepatic Steatosis and Attenuation Imaging.
Rehman A; Darira J; Hamid K; Ahmed MS; Shazlee MK; Amirali A
Cureus; 2022 Mar; 14(3):e23435. PubMed ID: 35494925
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Performance of 9 Quantitative Ultrasound Parameters for Detection and Classification of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
Pirmoazen AM; Khurana A; Loening AM; Liang T; Shamdasani V; Xie H; El Kaffas A; Kamaya A
Invest Radiol; 2022 Jan; 57(1):23-32. PubMed ID: 34049335
[TBL] [Abstract][Full Text] [Related]
27. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
Chan WK; Nik Mustapha NR; Mahadeva S
J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
[TBL] [Abstract][Full Text] [Related]
28. Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard.
Ferraioli G; Maiocchi L; Raciti MV; Tinelli C; De Silvestri A; Nichetti M; De Cata P; Rondanelli M; Chiovato L; Calliada F; Filice C
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00081. PubMed ID: 31609745
[TBL] [Abstract][Full Text] [Related]
29. Utility of quantitative ultrasound in community screening for hepatic steatosis.
Chang TY; Chang SH; Lin YH; Ho WC; Wang CY; Jeng WJ; Wan YL; Tsui PH
Ultrasonics; 2021 Mar; 111():106329. PubMed ID: 33338730
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of Ultrasound Attenuation Imaging for Assessing Pediatric Hepatic Steatosis.
Song K; Son NH; Chang DR; Chae HW; Shin HJ
Biology (Basel); 2022 Jul; 11(7):. PubMed ID: 36101465
[TBL] [Abstract][Full Text] [Related]
31. Liver Fat Quantification by Ultrasound in Children: A Prospective Study.
D'Hondt A; Rubesova E; Xie H; Shamdasani V; Barth RA
AJR Am J Roentgenol; 2021 Oct; 217(4):996-1006. PubMed ID: 33438457
[No Abstract] [Full Text] [Related]
32. Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease.
Draijer LG; Feddouli S; Bohte AE; Vd Baan Slootweg O; Pels Rijcken TH; Benninga MA; Stoker J; Koot BGP
Eur J Pediatr; 2019 Jun; 178(6):863-870. PubMed ID: 30903305
[TBL] [Abstract][Full Text] [Related]
33. Interest of hepatic steatosis index (HSI) in screening for metabolic steatopathy in patients with type 2 diabetes.
Fennoun H; Mansouri SE; Tahiri M; Haraj NE; Aziz SE; Hadad F; Hliwa W; Badr W; Chadli A
Pan Afr Med J; 2020; 37():270. PubMed ID: 33598084
[TBL] [Abstract][Full Text] [Related]
34. Hepatorenal Index by B-Mode Ratio Versus Imaging and Fatty Liver Index to Diagnose Steatosis in Alcohol-Related and Nonalcoholic Fatty Liver Disease.
Kjaergaard M; Lindvig KP; Hansen CD; Detlefsen S; Krag A; Thiele M
J Ultrasound Med; 2023 Feb; 42(2):487-496. PubMed ID: 35475550
[TBL] [Abstract][Full Text] [Related]
35. The most appropriate region-of-interest position for attenuation coefficient measurement in the evaluation of liver steatosis.
Sugimoto K; Abe M; Oshiro H; Takahashi H; Kakegawa T; Tomita Y; Yoshimasu Y; Takeuchi H; Itoi T
J Med Ultrason (2001); 2021 Oct; 48(4):615-621. PubMed ID: 34453648
[TBL] [Abstract][Full Text] [Related]
36. Two-dimensional Convolutional Neural Network Using Quantitative US for Noninvasive Assessment of Hepatic Steatosis in NAFLD.
Jeon SK; Lee JM; Joo I; Yoon JH; Lee G
Radiology; 2023 Apr; 307(1):e221510. PubMed ID: 36594835
[TBL] [Abstract][Full Text] [Related]
37. Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy.
Chang JW; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kim SU
Gut Liver; 2021 Jan; 15(1):117-127. PubMed ID: 32066210
[TBL] [Abstract][Full Text] [Related]
38. Hepatic steatosis: Ultrasound assessment using attenuation imaging (ATI) with liver biopsy correlation.
Welman CJ; Saunders J; Zelesco M; Abbott S; Boardman G; Ayonrinde OT
J Med Imaging Radiat Oncol; 2023 Feb; 67(1):45-53. PubMed ID: 35466506
[TBL] [Abstract][Full Text] [Related]
39. Controlled attenuation parameter in the diagnosis of different liver steatosis groups in children with obesity.
Yang L; Lin Y; Zhu YF; Zhu YY; Liang ZM; Wu GS
Pediatr Obes; 2022 Jun; 17(6):e12893. PubMed ID: 35092183
[TBL] [Abstract][Full Text] [Related]
40. CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease.
Kim HN; Jeon HJ; Choi HG; Kwon IS; Rou WS; Lee JE; Lee TH; Kim SH; Lee BS; Shin KS; Lee HJ; Eun HS
BMC Gastroenterol; 2023 Mar; 23(1):77. PubMed ID: 36932382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
